FFO
MDGL icon

Fortitude Family Office’s Madrigal Pharmaceuticals MDGL Stock Holding History

Fortitude Family Office’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Buy
2
+1
+100% +$478 ﹤0.01% 1504
2025
Q4 		$582 Hold
1
– – ﹤0.01% 1649
2025
Q3 		$459 Hold
1
– – ﹤0.01% 1838
2025
Q2 		$303 Hold
1
– – ﹤0.01% 1923
2025
Q1 		$331 Hold
1
– – ﹤0.01% 1100
2024
Q4 		$309 Hold
1
– – ﹤0.01% 1245
2024
Q3 		$212 Hold
1
– – ﹤0.01% 1187
2024
Q2 		$280 Hold
1
– – ﹤0.01% 931
2024
Q1 		$267 Hold
1
– – ﹤0.01% 946
2023
Q4 		$231 Buy
+1
New +$175 ﹤0.01% 988

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return